Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway

Expression of miR-106b-25 induced by salvianolic acid B inhibits epithelial-to-mesenchymal transition in HK-2 cells

(2014) Qiong Tang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

An investigation into anti-proliferative effects of microRNAs encoded by the miR-106a-363 cluster on human carcinoma cells and keratinocytes using microarray profiling of miRNA transcriptomes

(2014) Cuong Khuu et al.   Frontiers in Genetics

Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2

(2013) Xiaojian Ni et al.   CANCER SCIENCE

The role of RhoC in ovarian epithelial carcinoma: A marker for carcinogenesis, progression, prognosis, and target therapy

(2013) Yang Zhao et al.   GYNECOLOGIC ONCOLOGY

De-Regulated MicroRNAs in Pediatric Cancer Stem Cells Target Pathways Involved in Cell Proliferation, Cell Cycle and Development

(2013) Patricia C. Sanchez-Diaz et al.   PLoS One

Fibronectin induces MMP2 expression in human prostate cancer cells

(2012) Andrei Moroz et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Heading off with the herd: how cancer cells might maneuver supernumerary centrosomes for directional migration

(2012) Angela Ogden et al.   CANCER AND METASTASIS REVIEWS

MicroRNAs and the cell cycle

(2011) María José Bueno et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Mechanisms of microRNA deregulation in human cancer

(2011) Shan Deng et al.   CELL CYCLE

Shielding the messenger (RNA): microRNA-based anticancer therapies

(2011) Elena Sotillo et al.   PHARMACOLOGY & THERAPEUTICS

Matrix Metalloproteinases: Regulators of the Tumor Microenvironment

(2010) Kai Kessenbrock et al.   CELL

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

(2010) Chrisostomi Gialeli et al.   FEBS Journal

Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer

(2010) Kyung Sook Park et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

miRNAs in human cancer

(2010) Thalia A Farazi et al.   JOURNAL OF PATHOLOGY

RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9

(2009) Yang Zhao et al.   GYNECOLOGIC ONCOLOGY

The role of RhoC in growth and metastatic capacity of melanoma

(2009) Barbara Boone et al.   JOURNAL OF CUTANEOUS PATHOLOGY

RhoC Expression and Head and Neck Cancer Metastasis

(2009) M. Islam et al.   MOLECULAR CANCER RESEARCH

Causes and consequences of microRNA dysregulation in cancer

(2009) Carlo M. Croce   NATURE REVIEWS GENETICS

Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma

(2008) Hideyuki ABE et al.   BIOMEDICAL RESEARCH-TOKYO

Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation

(2008) D. Sampath et al.   BLOOD

Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer

(2008) S. Ambs et al.   CANCER RESEARCH

MicroRNA Expression Profiles in Serous Ovarian Carcinoma

(2008) E. J. Nam et al.   CLINICAL CANCER RESEARCH